Monthly Archives: September 2022

Dive Brief:

More employers, especially in the tech space, have highlighted neurodiverse hiring initiatives to attract and retain talent. Microsoft, for example, expanded its Neurodiversity Career Connector program earlier this year and has a dedicated neurodiversity hiring program, as well. Individuals who apply through the hiring program participate in an extended recruiting process that has recruiters engage more directly with participants, answering questions about interviewing, workability and skill assessment.

Various studies including Texthelps survey have shown that workers are supportive of neurodivergence inclusion at work; members of Gen Z are particularly supportive and tend to have keen interest in DEI overall. That means neurodivergent-inclusive programs can be a retention strategy for workers of all neurotypes.

Employers can improve inclusion by focusing intently on inclusive language and retrofitting interview structures. Many autistic workers, for example, find job interviews challenging because of struggles conforming to societal norms, an expert previously told HR Dive. Focusing on skills, rather than culture fit,can help an employer get a better sense of whether a candidate of any neurotype would be a good fit for the job. In-office accommodations for neurodivergent workers may also be easier than employers expect. And plain language workplace policies can benefit everyone, experts have said.

Read the original:

Neurodiverse inclusion is improving, but lack of awareness is blocking progress - HR Dive

The second-ever progress report of the Net-Zero Asset Owner Alliance shows consistent growth in membership, matched by the credibility of short-term decarbonisation targets.

On the day of the report release, the Alliance counts 74 members, accounting for US$ 10.6 trillion in assets under management. A third of that AUM US$ 7.1 trillion is now held by members who have set intermediate net-zero targets, aligned with the Target-Setting Protocol. The report offers insight into aggregate data on all four targets types: Engagement, Sub-portfolio, Sector and Financing Transition.

Beyond the targets, the report also highlights Alliances efforts in advocating for systemic policy changes that would enable a just transition, among them: a governmental carbon price, standardised data disclosures from companies and a cooperative environment for scaling blended finance. The Alliance also lists its five key asks from policymakers ahead of COP27.

For any media queries, contact Oliver Wagg and Teodora Cakarmis.

More:

The second progress report of the Net-Zero Asset Owner Alliance. Advancing delivery on decarbonisation targets. United Nations Environment Finance...

Last summer, WHQR began investigating a mold crisis at the Wilmington Housing Authority and it soon became clear that, due to severe mismanagement, it had become a humanitarian crisis with over a hundred families forced out of their homes. A detached board and negligent leadership had allowed the mold situation to get out of control. And when then-CEO Katrina Redmon quit in the midst of the crisis, the authority was spun out of control and at the brink of financial exhaustion, leaving families with no foreseeable end to their displacement.

WHQR's coverage: WHQR investigative series: The Wilmington Housing Authority's disastrous mismanagement of widespread mold

After months of reporting, local governments including the City of Wilmington and New Hanover County finally started speaking up, putting pressure on WHA, and pitching in to help the hundreds of displaced residents.

Earlier this year, in May, WHA finally hired a new director Tyrone Garrett, who had decades of experience, but also some serious baggage.

After three months on the job, WHQR's Ben Schachtman and Kelly Kenoyer caught up with Garrett to ask how he was handling the situation.

Ben Schachtman: So Kelly, you went to WHAs board meeting last week. Whats the update?

Kelly Kenoyer: Well back in July, there were 150 families displaced from their housing. Now, that number is down to 131.

BS: Thats progress, but thats not nearly fast enough to get everyone back in their apartments by the end of the year. Which was the Authoritys goal, according to the new executive director, Tyrone Garrett.

KK: He was pretty ambitious when he came in, its true. But I will say, its going a lot faster than it was under Katrina Redmons leadership, and certainly much faster than when the agency was rudderless.

BS: How exactly did he manage that?

KK: Well, its a strategy shift. Garrett came in and decided that, instead of fixing every single problem in a unit while it was empty, they would cap repairs at $20,000 and only fix the health-related problems, like the severe mold issues.

Garrett: I think we have a good plan. Now, the average on average, what we look to have is about 20 units per month coming back online.

BS: 20 units per month, that puts at what, 80 by the end of the year?

KK: Yeah, they have four contractors working on it. And actually, Garrett said no to an offer by some local non-profits to help with repairs.

BS: No kidding? Who offered to help?

KK: New Hanover Disaster Coalitions Derek McCleod told me they made a big offer a couple weeks ago.

McCleod: We had presented a plan with Catholic Charities to help do some mold remediation. And we were told we were not needed.

BS: Thats really surprising.

KK: McCleod said he was frustrated by it it would be free labor to get units online, after all, and these are licensed contractors. But Garrett had his reasons for rejecting the offer.

Garrett: No, no, this was something I thought we should take on ourselves. There's a liability that's associated with it too, right? Most people won't be able to take on that type, it needs to be on the housing authority to move forward. I think, if we were in a position where we didn't have a plan, then we might be seeking other avenues.

BS: Thats right and he said his plan with these contractors is working. They might ask nonprofits for more help with furniture for residents or social services, but not for capital costs.

KK: That still leaves a big number of people unhoused by Christmas, even if his 20 families per month goal stays on track.

BS: Yeah, it would leave 51 families still living in hotels or corporate apartments. But Garrett said theyre hoping to help more of them with another program.

Garrett: We're also using the Housing Choice Voucher Program at the same time. So the Housing Choice Voucher Program is the mechanism what people call Section 8, that allows for families that go outside of the quote unquote, conventional public housing, housing stock, we're using that program at the same time. So so far, I think we've had approximately 10 families go into that particular direction with at least another 25 vouchers that are out on the street."

KK: So Garrett had actually said that there are 70 vouchers available, but he thinks that number wont be fully supported by the marketplace. Those vouchers can be used on regular rentals, but a lot of landlords discriminate against Housing Choice, so he says the 25 number is more realistic.

BS: So were looking at perhaps 105 families back in permanent housing by the end of the year, with 25 or 26 still in hotels or corporate apartments.

KK: Thats a lot better prospects than last fall, though, when there was no plan. Ben, is there anything else we want to mention about Garretts leadership?

BS: Well, he mentioned that hes gotten rid of some bad apples among his managers, and hes brought in a new executive team. Weve heard complaints from some residents about managers who ignore their complaints, so thats a big change. And he also promised to address work orders a lot faster.

Garrett: I've instituted a three-day work order rule, meaning that a normal routine work order that goes into play has to be completed within three days. Now we're not there yet. But that's what we have to strive for.

BS: So even if things arent perfect at WHA, were looking at an organization with aspirations, which is quite different from what we saw a year ago as Katrina Redmon left the organization.

KK: Well keep following this as it goes on, and as WHA looks beyond the mold crisis and towards building more housing in the future. Thanks Ben!

BS: Thanks Kelly.

Read this article:

Over a year into the mold crisis, WHA's new leader says progress is being made - WHQR

PDC Energy, Inc.

DENVER, Sept. 19, 2022 (GLOBE NEWSWIRE) -- PDC Energy, Inc. (PDC or the Company) (Nasdaq: PDCE) announced today the publication of the Company's 2022 environmental, social and governance (ESG) materials. The 2022 ESG reports are aligned with the Sustainability Accounting Standards Board (SASB), the Taskforce on Climate-related Financial Disclosures (TCFD), and the American Exploration and Production Council (AXPC) ESG metrics framework.

As a leader in the energy industry, we understand it is incumbent upon us to safely develop the domestic energy needed to power our world, said Bart Brookman, President and Chief Executive Officer of PDC. At PDC, we are committed to ongoing environmental stewardship, aggressive emissions reduction goals, and the complete elimination of routine flaring as we foster strong, transparent relationships with our communities.

I am of proud the progress our team has made in our ESG program over the last three years we have been formally reporting. Our ESG journey has been one characterized by thoughtful and incremental progress, and its clear that 2021 and early 2022 marked a significant leap in our emergence as a forward-looking leader in this space.

Key highlights from the look back on 2021 include:

17% year-over year reduction in methane emissions

12% year-over year reduction in GHG intensity

More than 7,200 volunteer hours given by PDC employees in 2021

Added new ESG metrics to executive compensation

90% of PDCs board has been added in the last five years including the addition of three diverse members since early 2021

Expanded reporting framework to include Taskforce on Climate-related Financial Disclosures (TCFD) and responded to the CDP climate change questionnaire, providing detailed information on topics including emissions management and governance and policy engagement

Continued 2022 progress highlighted in the reports include:

PDC acquired Great Western Petroleum, a DJ Basin asset accretive to our ESG initiatives

Joined the Oil and Gas Methane Partnership (OGMP 2.0), a comprehensive, measurement-based reporting framework for the oil and gas industry that improves accuracy and transparency of methane emissions reporting

Both the DJ Basin and Delaware Basin assets surpassed four years without an employee Lost Time Incident

Developed and adopted Human Rights and Political Engagement policies and added corruption and bribery language to our Code of Business Conduct and Ethics

Story continues

PDC remains committed to its long-term greenhouse gas and methane emission intensity reduction goals of 60% and 50%, respectively, by 2025 and reduction goals of 74% and 70%, respectively, by 2030. Additionally, we remain on track to eliminate routine flaring by 2025.

PDC has published several reports as a part of the Company's 2022 ESG materials designed to provide a roadmap on progress of our key metrics, material initiatives and successes. Reports include:

2022 Corporate Social Responsibility Report (A Look Back on 2021)

Sustainability Accounting Standards Board (SASB)

Taskforce on Climate-Related Financial Disclosures (TCFD)

Key Metrics and Performance Highlights, including American Exploration and Production Council (AXPC) ESG metrics framework

For more information about PDCs sustainability efforts and to download the 2022 ESG reports, please visit http://www.pdce.com.

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 (Securities Act), Section 21E of the Securities Exchange Act of 1934 (Exchange Act), and the United States (U.S.) Private Securities Litigation Reform Act of 1995 regarding the Companys expectations of future permit applications approvals, planned operating activity and inventory expectations. All statements other than statements of historical fact included in and incorporated by reference into this press release are forward-looking statements.

PDC cautions you not to place undue reliance on the forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to update any forward-looking statements in order to reflect any event or circumstance occurring after the date of this press release or currently unknown facts or conditions or the occurrence of unanticipated events. All forward-looking statements are qualified in their entirety by this cautionary statement.

Contacts:

Courtney Loper

Director Stakeholder Relations

(303) 831-3997

Courtney.Loper@pdce.com

Aaron Vandeford

Director Investor Relations

303-318-9493

Aaron.Vandeford@pdce.com

View post:

PDC Energy Publishes Annual Environmental, Social and Governance (ESG) Materials Highlighting Progress on Key Metrics and Material Initiatives - Yahoo...

INNIO announced that EcoVadis has awarded the INNIO Group, including its Jenbacher and Waukesha product lines, with a platinum medal as part of its sustainability performance rating, placing INNIO in the top 1% of all businesses evaluated by EcoVadis.

Founded in Paris in 2007, EcoVadis is one of the worlds largest providers of business sustainability ratings, with a global network of more than 100,000+ rated companies.

INNIO said the platinum award reflects demonstrated improvements and contributions towards sustainable growth in the past year, with notable score improvement in Environment, and Sustainable Procurement and continued strong performance in Labor & Human Rights and Ethics categories.

I am extremely proud that INNIO has been awarded the EcoVadis platinum medal, said Olaf Berlien, president and CEO of INNIO. After having already been ranked number one globally amongst companies with the lowest risk within the machinery industry by Sustainalytics, EcoVadis now places us among the top 1% of all evaluated businesses worldwide.

This demonstrates INNIOs commitment to empowering the net zero transition while ensuring that our employees are fully engaged at the workplace and providing continuous support through our diversity and inclusion efforts.

EcoVadis annual assessment focuses on 21 issues grouped into themes that include: environment, labor & human rights, ethics, sustainable procurement, and a dedicated scorecard on carbon. These criteria are based upon international sustainability standards, including the Global Compact Principles, the International Labour Organization Conventions, and the Global Reporting Initiative standard. The platinum medal rating reflects INNIOs continued commitment to its sustainability efforts in 2022.

See the rest here:

INNIO cited for progress and execution of ESG strategy - COMPRESSORtech2

TORONTO, ON / ACCESSWIRE / September 20, 2022 / Gratomic Inc. ("Gratomic", "GRAT," or the "Company") (TSXV:GRAT)(OTCQX:CBULF)(FSE:CB82) announces its progress update on the earth moving activities at its Flagship Aukam Graphite Project in Namibia, further to its press release dated September 7, 2022. The benching process typically involves successively cutting berms alongside the mountain edge in order to steadily expose underground material, at the same time ensuring the stability of the mountain structure. This process allows for the collection of graphite in stages as the plaforms are constructed on the Aukam mountain.

During the past several weeks, road construction was completed to the upper part of the mountain, and actual benching of the mountain side began in earnest. During the process, the team intercepted its first mineralized vein and started movig material to the ROM pad. A representative sample of the material will be sent to the laboratory to confirm grade.

This interception is in line with the expectations of the Company's mining engineering team, which reinforces the team's understanding about the results to be achieved as the program advances.

Arno Brand, President & CEO, states, "I am very pleased to witness the rapid progress being made by our in-house mining team. The first intercept of graphite came weeks ahead of expectation and brings forth a great deal of excitement as we steadily prepare to re-launch mining operations at Aukam for the first time in 46 years. Our recent financing secured our ability to complete our benching and initial mining programs."

"It is comforting to see that the expectations of our technical team are being met, increasing our confidence level on the success of this benching program", says Armando Farhate, COO & Head of Graphite Marketing & Sales.

Gratomic wishes to emphasize that no Preliminary Economic Analysis, Preliminary Feasibility Study or Feasibility Study has been completed to support any level of production. In fact, no mineral resources let alone mineral reserves demonstrating economic viability and technical feasibility, have been delineated on the Aukam property.

The Company is working towards completing a Feasibility Study (FS) on the Aukam Processing plant. The study, its recommendations, and their subsequent implementation, will provide conclusions and recommendation at a FS level of comfort relating to the scale up of the existing processing plant to a commercial scale processing facility capable of producing the desired concentrate grades and production rates.

Gratomic wishes to emphasize that the supply of graphite is conditional on Gratomic being able to bring the Aukam project into a production phase, and for any graphite being produced to meet certain technical and mineralization requirements.

Risk Factors

No mineral resources, let alone mineral reserves demonstrating economic viability and technical feasibility, have been delineated on the Aukam Property. The Company is not in a position to demonstrate or disclose any capital and/or operating costs that may be associated with the processing plant until the FS (Feasibility Study) is completed.

The Company advises that it has not based its production decision on even the existence of mineral resources let alone on a Preliminary Feasibility Study or FS of mineral reserves, demonstrating economic and technical viability, and, as a result, there may be an increased uncertainty of achieving any particular level of recovery of minerals or the cost of such recovery, including increased risks associated with developing a commercially mineable deposit.

Historically, such projects have a much higher risk of economic and technical failure. There is no guarantee that production will begin as anticipated or at all or that anticipated production costs will be achieved.

Failure to commence production would have a material adverse impact on the Company's ability to generate revenue and cash flow to fund operations. Failure to achieve the anticipated production costs would have a material adverse impact on the Company's cash flow and future profitability.

About Gratomic

Gratomic is a multinational company with projects in Namibia, Brazil, and Canada. The Company is focused on becoming a leading global graphite supplier and aims to secure a strong position in the EV battery supply chain. With the continued development of its flagship Aukam project and further exploration on the Company's Capim Grosso property, Gratomic sets itself apart by seeking out unique top-quality assets around the world. True to its roots, the Company will continue to explore graphite opportunities displaying potential for development. The Company ranked third place in the top 10 preforming mining stocks on the 2022 TSX Venture 50.

Large quantities of high-quality vein graphite have been shipped for testing to confirm its viability as an anode material. Gratomic is confident that the test results will provide a unique competitive advantage in its desired target markets. The Company will continue to update the public on the status of these tests and will provide results as soon as they become available.

The Company has formed a collaboration agreement with Forge Nano. With its patented ALD coating, this cooperation with Forge Nano is a key element to support Gratomic's strategies towards the value-added phases of production of graphite for anode applications, namely micronization, spheronization and coating, making Gratomic graphite a preferred choice for use in lithium-ion batteries.

For more information: visit the website at http://www.gratomic.ca or contact:

Arno Brand at [emailprotected] or (416) 561- 4095

Subscribe at gratomic.ca/contact/ to be added to our email list.

For Marketing and Media information, please email: [emailprotected]

"Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release."

Forward Looking Statements:

This news release contains forward-looking statements, which relate to future events or future performance and reflect management's current expectations and assumptions. Such forward-looking statements reflect management's current beliefs and are based on assumptions made by and information currently available to the Company. Investors are cautioned that these forward-looking statements are neither promises nor guarantees and are subject to risks and uncertainties that may cause future results to differ materially from those expected. These forward-looking statements are made as of the date hereof and, except as required under applicable securities legislation, the Company does not assume any obligation to update or revise them to reflect new events or circumstances. All of the forward-looking statements made in this press release are qualified by these cautionary statements and by those made in our filings with SEDAR in Canada (available at http://www.sedar.com)

SOURCE: Gratomic Inc.

The rest is here:

Gratomic Announces Second Progress Update on Benching Program at its Aukam Project in Namibia - AccessWire

Brian Miller spoke with Deputy Bryan Hicks and his wife one year after he was shot in the head.

September 18, 2021 is when the darkness and uncertainty set in for Posey County Deputy Bryan Hicks.

He was shot in the head during a welfare check at a home in New Harmony. He nearly lost his life.

But fast forward one year later and the times are a bit brighter for the deputy and his wife Tammy.

Brian can speak in full sentences now with the help of a computer program he uses in his speech therapy sessions.

While Bryan still has difficulty finding the words, his wife Tammy has learned to pick up the slack.

Tammy says she wasn't shocked to learn Bryan had been shot that night. After all, she says, he made it clear that he would always be the first officer to go into a dangerous situation, risking his own life and safety for others.

The suspect, 70-year-old Paul Wiltshire, died of COVID-19 complications about three months after being charged with attempted murder of a police officer.

If there's any silver lining; any positivity to come from the despair and devastation this couple has no doubt felt, it's all of the items and get-well cards that came from around the nation.

As for what's next, Bryan says there's one thing that still drives him.

"My goal is to drive again and work again," he said.

Bryan is proud of his career and proudly displays his mementos, paying homage to the career choice that made him who he is today.

Here is the original post:

Posey County deputy who was shot in the head is making progress, wants to return to his job - WEVV

JERUSALEM, Sept. 20, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd.(Nasdaq: BVXV), which focuses on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses, today provided encouraging updates related to the strategic research collaboration between BiondVax, the Max Planck Institute for Multidisciplinary Sciences (MPG), and the University Medical Center Gttingen (UMG) towards the development of a pipeline of innovative alpacaderived nanosized antibody (NanoAb) therapies.

As reported in March 2022, in addition to the exclusive license for the ongoing development and commercialization of an inhaled COVID-19 NanoAb therapy, the parties signed a five-year research collaboration agreement (RCA) for additional NanoAbs for the treatment of diseases such as psoriasis, psoriatic arthritis, asthma, and wet macular degeneration. Today, BiondVax reported that Professor Dirk Grlich of MPG and his team have successfully generated, identified and isolated NanoAbs addressing a number of additional biological target molecules as specified in the relevant RCA. Professor Grlich and his colleague Professor Matthias Dobbelstein of UMG verified strong affinity by the new NanoAbs to their biological target molecules and high thermostability. The academic research teams have also demonstrated strong neutralization by several NanoAb candidates of their respective target molecules. Neutralization studies of the other NanoAbs are expected to begin later this year.

Based on these promising results, the BiondVax-MPG-UMG Joint Steering Committee, established to guide the NanoAb collaboration, decided earlier this month to focus further development beginning with the following NanoAbs, targeting immune system cytokines:

Derisked strategy: This advancement is aligned with BiondVax's derisked R&D strategy as these cytokine targets are already validated to exert beneficial clinical results in human beings when treated with conventional monoclonal antibodies. Moreover, these conventional monoclonal antibodies are already approved for marketing and generate billions of dollars in annual commercial sales. The BiondVax-MPG-UMG research collaboration team aims to generate and develop NanoAbs with the potential to capture significant market share as "bio-betters" answering needs underserved by currently approved conventional monoclonal antibody therapeutics as the NanoAbs exhibit strong potential for superior patient convenience, safety, and clinical outcomes, at lower costs. Pursuant to the RCA, BiondVax holds exclusive options for worldwide exclusive licenses to further develop and commercialize these NanoAbs.

Inhaled COVID-19 therapy: These new NanoAbs are in addition to the ongoing development of a previously announced COVID-19 NanoAb therapy exclusively licensed to BiondVax from Max Planck Innovation GmbH, which acts as the technology transfer agency of MPG. In the coming weeks, BiondVax intends to initiate a preclinical proof-of-concept study of the COVID-19 NanoAb as an inhaled therapy in COVID-19 infected animals. The study will be conducted in collaboration with two world renowned institutions: The Fraunhofer Institute for Toxicology and Experimental Medicine ITEM and The University of Veterinary Medicine Hannover (TiHo), Germany. Assuming successful results, a first-in-human Phase 1/2a clinical trial of the COVID-19 NanoAb inhaled therapy will be initiated in 2023.

Mr. Amir Reichman, BiondVax's Chief Executive Officer, noted, "The next two targets we have decided to pursue, asthma and psoriasis, are both conditions for which the antibody target is validated by existing treatments for which the mechanism of action is well understood. Both represent large and growing markets. We strongly believe in the potential of our NanoAbs to be 'bio-betters' compared to the existing treatments, in that the NanoAbs are expected to demonstrate very high potency, safety, stability and with convenient routes of delivery to patients at an affordable cost. Thanks to the leading scientific support provided by Professor Dirk Grlich and Professor Matthias Dobbelstein and their teams at Max Planck and UMG, we are confidently working with urgency to bring more drug candidates of this exciting NanoAb therapy platform to the market as soon as possible."

About BiondVaxBiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses. Since its inception, the company has executed eight clinical trials including a seven country, 12,400 participant Phase 3 trial of its vaccine candidate and has built a state-of-the-art manufacturing facility for biopharmaceutical products. With highly experienced pharmaceutical industry leadership, BiondVax is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized antibody (NanoAb) pipeline. http://www.biondvax.com.

Contact DetailsCompany: Joshua E. Phillipson | +972 8 930 2529 | j.phillipson@biondvax.com

Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Litigation Reform Act of 1995. Words such as "expect," "believe," "intend," "plan," "continue," "may," "will," "anticipate," and similar expressions are intended to identify forward-looking statements. All statements, other than statements of historical facts, included in this communication regarding strategy, future operations, future financial position, future revenue, projected expenses, prospects, plans and objectives of management are forward-looking statements. Examples of such statements include, but are not limited to, the therapeutic and commercial potential of nanosized antibodies (NanoAbs); and the timing of NanoAb proof-of-concept studies and clinical trials. These forward-looking statements reflect management's current views with respect to certain current and future events and are subject to various risks, uncertainties and assumptions that could cause the results to differ materially from those expected by the management of BiondVax Pharmaceuticals Ltd. Risks and uncertainties include, but are not limited to, the risk that the therapeutic and commercial potential of NanoAbs will not be met; the risk of a delay in the preclinical and clinical data for NanoAbs, if any; the risk that BiondVax may not be able to secure additional capital on attractive terms, if at all; risks relating to the COVID-19 (coronavirus) pandemic; BiondVax's ability to acquire rights to additional product opportunities; BiondVax's ability to enter into collaborations on terms acceptable to BiondVax or at all; timing of receipt of regulatory approval of BiondVax's manufacturing facility in Jerusalem, if at all or when required; the risk that the manufacturing facility will not be able to be used for a wide variety of applications and other vaccine and treatment technologies, and the risk that drug development involves a lengthy and expensive process with uncertain outcomes. More detailed information about the risks and uncertainties affecting the Company is contained under the heading "Risk Factors" in the Company's Annual Report on Form 20-F filed with the Securities and Exchange Commission on March 28, 2022. BiondVax undertakes no obligation to revise or update any forward-looking statement for any reason.

Logo - https://mma.prnewswire.com/media/615570/BiondVax_Pharmaceuticals_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/biondvaxs-strategic-research-collaboration-with-max-planck-and-umg-significant-progress-towards-development-of-innovative-nanosized-antibodies-nanoabs-for-therapeutic-indications-in-addition-to-covid-19-301627924.html

SOURCE BiondVax Pharmaceuticals Ltd.

Company Codes: NASDAQ-SMALL:BVXV

See more here:

BiondVax's Strategic Research Collaboration with Max Planck and UMG: Significant progress towards development of innovative nanosized antibodies...

On September 14th, Lindsey Graham of South Carolina introduced a national 15-week abortion ban bill into the Senate less than three months after the fall of Roe.

Whats important to note is that, Grahams proposed bill wouldnt get rid of total abortion bans in red states that prevent abortions before 15-weeks. This would stop states from being able to provide abortions beyond 15 weeks.

Grahams bill clearly disproves Republicans long-held claim that abortion rights should be up to the states and proves what conservative politicians are actually after: government overreach by enacting control over our bodies and medical decisions.

But that South Carolina drawl aint charming other Republicans. If you havent noticed, most conservative pundits and politicians have been silent on the subject of abortion lately. But this is not because theyve slithered back into their dark dreary caves. Its because Republicans have received national backlash over the fall of Roe and they are seeing polls prove that most Americans support access to abortion. In addition, more young folks, women and LGBTQ folks are registering to vote - motivated by the fall of Roe. This spells disaster for Republicans in the upcoming November election.

In short, Grahams bill is a sad attempt to win Republicans votes and talking points for Novembers election but now that the genie is out of the bottle, its too late to put it back in. Sothank you Lindsey? For reminding Americans what your party truly stands for: anti-abortion, anti-freedom and anti-moisturizing. Lets take back our country and our rights this November and make sure you and your friends are registered to vote by checking govotetexas.org.

Want to hear more hot-takes from the Progress Texas staff on this proposed 15-week abortion ban? Check out our latest podcast here where we share our thoughts. And last but not least, dont forget to join the Roevolution, our campaign to fight for abortion access!

View original post here:

Trolling themselves: the Republican 15-week national abortion blunder - Progress Texas

An accomplished attorney and national expert in food safety, William (Bill) Marler has become the most prominent foodborne illness lawyer in America with his firm, Marler Clark: The Food Safety Law Firm, and a major force in food policy in the U.S. and around the world. For the past 26 years, Bill has represented victims of nearly every large foodborne illness outbreak in the U.S. He began litigating foodborne illness cases in 1993, when he represented Brianne Kiner, the most seriously injured survivor of the historic Jack in the Box E. coli O157:H7 outbreak, in her landmark $15.6-million settlement with the company. The 2011 book, Poisoned, by best-selling author Jeff Benedict, chronicles the Jack in the Box outbreak and the rise of Bill Marler as a food safety attorney.

Bill's advocacy for a safer food supply includes petitioning the U.S. Department of Agriculture to better regulate pathogenic E. coli, working with nonprofit food safety and foodborne illness victims' organizations, and helping spur the passage of the 20102011 FDA Food Safety Modernization Act (FSMA). His work has led to invitations to address local, national, and international gatherings on food safety, including testimony before the U.S. House of Representatives Committee on Energy and Commerce.

Bill travels widely and frequently to speak to food industry groups, fair associations, and public health groups about the litigation of claims resulting from outbreaks of pathogenic bacteria and viruses and the issues surrounding them. He gives frequent donations to industry groups for the promotion of improved food safety, and has established numerous collegiate science scholarships across the U.S. He is also a frequent writer on topics related to foodborne illness and the Publisher of the online news site, Food Safety News, and his award-winning blog, http://www.marlerblog.com. He is frequent media guest on food safety issues and has been profiled in numerous publications.

In 2010, Bill was awarded the NSF Food Safety Leadership Award for Education, and in 2008 he earned the Outstanding Lawyer Award by the King County Bar Association. He has also received the Public Justice Award from the Washington State Trial Lawyers Association. Bill graduated from the Seattle University School of Law in 1987, and in 1998 was the Law School's "Lawyer in Residence." In 2011, he was given Seattle University's Professional Achievement Award. He is a member of the board of directors of Bainbridge Youth Services and a member of the Children's Hospital Circle of Care.

We Want to Hear from You!

Please send us your questions and suggestions to podcast@food-safety.com

See original here:

Ep. 128. Bill Marler: Perspectives on Poisoned and Food Safety Progress - Food Safety Magazine